GLPBio

Microbiology & Virology

Read More about this category
Microbiology & Virology

Microbiology & Virology

A virus is a small infectious agent that replicates inside living cells. Viruses cause many human diseases from small illnesses, like influenza, to more deadly diseases, like hepatitis B and HIV. Our body’s immune system defends against viral infection by generating specific antibodies to bind to and neutralize viral particles and by cell mediated immunity that destroys infected host cells.

Research Areas

Products Related to Microbiology & Virology(3916)

  • GC72402 structure
    GC72402Vilobelimab
    CAS: 2250440-41-4
    Purity: >99.00%

    Vilobelimab (CaCP-29, IFX-1) is a monoclonal anti-C5a antibody to the allergen C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction.

  • GC72404 structure
    GC72404Tixagevimab
    CAS: 2420564-02-7
    Purity: 95.00%

    Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD).

  • GC72405 structure
    GC72405Raxibacumab
    CAS: 565451-13-0
    Purity: >98.00%

    Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA).

  • GC72409 structure
    GC72409Suvratoxumab
    CAS: 1629620-18-3
    Purity: >98.00%

    Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-α-toxin monoclonal antibody (IgG1κ type).

  • GC72412 structure
    GC72412Cilgavimab
    CAS: 2420563-99-9
    Purity: 95.00%

    Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab .

  • GC72414 structure
    GC72414Firivumab
    CAS: 1443004-15-6
    Purity: 95.00%

    Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody.

  • GC72421 structure
    GC72421Larcaviximab
    CAS: 1792982-56-9
    Purity: >96.00%

    Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody.

  • GC72425 structure
    GC72425Maftivimab
    CAS: 2135632-36-7
    Purity: >96.00%

    Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent.

  • GC72432 structure
    GC72432Navivumab
    CAS: 1443004-16-7
    Purity: >99.00%

    Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2.

  • GC72434 structure
    GC72434Odesivimab
    CAS: 2135632-30-1
    Purity: >99.00%

    Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein.

  • GC72436 structure
    GC72436Porgaviximab
    CAS: 1792982-55-8
    Purity: 98.00%

    Porgaviximab is a monoclonal antibody that can be used Ebola infection research.

  • GC72442 structure
    GC72442Quisovalimab
    CAS: 2427667-03-4
    Purity: >96.00%

    Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19.

  • GC72446 structure
    GC72446Cosfroviximab
    CAS: 1792982-57-0
    Purity: 95.00%

    Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP).

  • GC72450 structure
    GC72450Diridavumab
    CAS: 1393659-46-5

    Diridavumab is a monoclonal anti-HA stalk antibody.

  • GC72460 structure
    GC72460Romlusevimab
    CAS: 2509447-08-7
    Purity: 95.00%

    Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

  • GC72470 structure
    GC72470Elipovimab
    CAS: 2101210-43-7
    Purity: >97.00%

    Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cellsReferences:.

  • GC72480 structure
    GC72480Stilbamidine dihydrochloride
    CAS: 6935-63-3
    Purity: >95.00%

    Stilbamidine dihydrochloride is a diamidine compound derived from Stilbene and used chiefly in the form of its crystalline isethionate salt in treating various fungal infections.

  • GC72496 structure
    GC72496Skatole-d8
    CAS: 697807-03-7
    Purity: >98.50%

    Skatole-d8 is the deuterium labeled Skatole.

  • GC72510 structure
    GC72510TbPTR1 inhibitor 2
    CAS: 17557-67-4
    Purity: >99.00%

    TbPTR1 inhibitor 2 (Compound 3a) is a PTR1 enzyme inhibitor, with IC50s of 34.2 and 32.9 μM for TbPTR1 and LmPTR1.

  • GC72515 structure
    GC72515Methylisothiazolinone-d3 hydrochloride
    CAS: 1329509-49-0

    Methylisothiazolinone-d3 (hydrochloride) is the deuterium labeled Methylisothiazolinone (hydrochloride).

  • GC72521 structure
    GC725212-Chloroacetamide
    CAS: 79-07-2
    Purity: >98.00%

    2-Chloroacetamide is a preservative and is a herbicide for both uplands and paddy fields.

  • GC72542 structure
    GC72542N4-Acetylsulfamethoxazole-d4
    CAS: 1215530-54-3

    N4-Acetylsulfamethoxazole-d4 is the deuterium labeled N4-Acetylsulfamethoxazole.

  • GC72550 structure
    GC72550Fmoc-Pro-OH-13C5,15N
    CAS: 1217452-48-6

    Fmoc-Pro-OH-13C5,15N is a 15N-labeled and 13C-labled Pyrimethanil.

  • GC72584 structure
    GC72584Benzisothiazolinone-13C5
    CAS: 1329616-16-1

    Benzisothiazolinone-13C5 (1,2-Benzothiazol-3-one-13C5) is a 13C-labeled Benzisothiazolinone.